FB Nasdaq FB Facebook

Biotech Active Runners: Novavax (NASDAQ:NVAX), VIVUS (NASDAQ:VVUS), Rexahn Pharmaceuticals (NYSEMKT:RNN), Ariad Pharmaceuticals (NASDAQ:ARIA)

Novavax, Inc. (NASDAQ:NVAX), announced on Thursday that the Biomedical Advanced Research and Development authority extended the base period of performance of a contract with the pharmaceutical company for its recombinant seasonal and pandemic influenza vaccines. Novavax, Inc. (NASDAQ:NVAX) stock performance was 1.27% in last session and finished the day at $6.38. Traded volume was 13,436,282 million shares in the last session and the average volume … Continue reading Biotech Active Runners: Novavax (NASDAQ:NVAX), VIVUS (NASDAQ:VVUS), Rexahn Pharmaceuticals (NYSEMKT:RNN), Ariad Pharmaceuticals (NASDAQ:ARIA)

Colin Pettis03/0503/05

Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

VIVUS Inc. (NASDAQ:VVUS) stock was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $8.00 price target on the stock, down previously from $15.00. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 1.00% in last session and finished the day at $6.09. Traded volume was 5,364,675 million shares in the last session and the average volume … Continue reading Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Mark DeFrance03/0403/04

Investors Watch List : Johnson & Johnson (NYSE:JNJ), VIVUS Inc. (NASDAQ:VVUS), SVB Financial Group (NASDAQ:SIVB), AT&T, Inc. (NYSE:T), Modine Manufacturing Company (NYSE:MOD)

Johnson & Johnson (NYSE:JNJ) said on Tuesday that it would pay $1.75 billion in cash for Alios BioPharma, a private biotechnology company that is working on treatments for viral diseases. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 21.20% and weekly performance is -3.03%. On last trading day company shares ended up $103.85. Johnson & Johnson (NYSE:JNJ) distance from 50-day … Continue reading Investors Watch List : Johnson & Johnson (NYSE:JNJ), VIVUS Inc. (NASDAQ:VVUS), SVB Financial Group (NASDAQ:SIVB), AT&T, Inc. (NYSE:T), Modine Manufacturing Company (NYSE:MOD)

Chris Lewis10/0310/03

News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),

Ariad Pharmaceuticals (NASDAQ:ARIA Director Sarah J. Schlesinger bought 5,200 shares of Ariad Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, September 10th. The shares were purchased at an average cost of $5.73 per share, with a total value of $29,796.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.27%. On last trading day company shares ended … Continue reading News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),

Colin Pettis09/2409/24

Active Watch List : VIVUS Inc. (NASDAQ:VVUS), Arch Coal Inc. (NYSE:ACI), FXCM Inc. (NYSE:FXCM), U.S. Global Investors (NASDAQ:GROW), Select Income REIT Common (NYSE:SIR)

VIVUS Inc. (NASDAQ:VVUS) The company on Aug. 25 announced the acquisition of a group of patents from Janssen Pharmaceuticals, Inc. covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware … Continue reading Active Watch List : VIVUS Inc. (NASDAQ:VVUS), Arch Coal Inc. (NYSE:ACI), FXCM Inc. (NYSE:FXCM), U.S. Global Investors (NASDAQ:GROW), Select Income REIT Common (NYSE:SIR)

Kristen Barton09/1609/16

Trending Stocks : VIVUS Inc. (NASDAQ:VVUS), VeriSign (NASDAQ:VRSN), Oil-Dri Corp. of America (NYSE:ODC), Orbital Sciences Corp. (NYSE:ORB), Telecom Italia S.p.A. (NYSE:TI)

VIVUS, Inc. (NASDAQ:VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the second quarter ended June 30, 2014 and provided a business update. Total net revenue was $21.9 million for the second quarter of 2014, compared to $5.5 million for the second quarter of 2013. Of the total revenue for the … Continue reading Trending Stocks : VIVUS Inc. (NASDAQ:VVUS), VeriSign (NASDAQ:VRSN), Oil-Dri Corp. of America (NYSE:ODC), Orbital Sciences Corp. (NYSE:ORB), Telecom Italia S.p.A. (NYSE:TI)

Colin Pettis08/0808/08